Jounce Therapeutics, Inc. - FORM 10-K - EX-21.1 - EXHIBIT 21.1 - February 27, 2020

Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - Jounce Therapeutics, Inc.jnce12312019exhibit321.htm
EX-31.2 - EXHIBIT 31.2 - Jounce Therapeutics, Inc.jnce12312019exhibit312.htm
EX-31.1 - EXHIBIT 31.1 - Jounce Therapeutics, Inc.jnce12312019exhibit311.htm
EX-23.1 - EXHIBIT 23.1 - Jounce Therapeutics, Inc.jnce12312019exhibit231.htm
EX-4.3 - EXHIBIT 4.3 - Jounce Therapeutics, Inc.jnce12312019exhibit43.htm
10-K - 10-K - Jounce Therapeutics, Inc.jnce1231201910-k.htm


Exhibit 21.1
Subsidiaries of the Registrant
Name
 
Jurisdiction of Organization
 
Percentage Ownership
Jounce Mass Securities, Inc.
 
Massachusetts
 
100%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




Jounce Therapeutics, Inc. Reports